[Assessment of Risk of Development of Diabetes Mellitus Among Physicians of Therapeutic Proffle: Results of a Screening Study].

AIM: to assess risk of development of diabetes mellitus (DM) and detection of other metabolic derangements among physicians-internists. MATERIAL AND METHODS: In an open clinical screening study participated 117 male and 167 female physicians mostly cardiologists and internists from various regions of Russia. All participants filled in standard questionnaires and were subjected to examination which included measurement of height, body mass, waist circumference, determination of adipose tissue mass adiposity analyzer, registration of arterial pressure, and assessment of DM risk using Finnish Diabetes Risk Score (FINDRISC). RESULTS: Each second physician had high value of adipose mass volume. Abdominal obesity was found in every third participant irrespective of age. High AP values were detected in 53% of men and 21% of women. Every sixth respondent had moderate or high risk of DM. Moderate risk among men was 2.5 high than in women while high and very high risk was 2 times more frequent in women. CONCLUSION: Because of high prevalence of metabolic disturbances primary prevention is a pressing in this social group.

[Monitoring the Secondary Prevention of Coronary Artery Disease in Europe and Russia: Results of the Russian Part of the International Multicenter Study EUROASPIRE IV].

The results of the Russian part of the EUROASPIRE IV study show that we have a large room for improvement of traditional risk factors management in CAD patients hospitalized for acute myocardial infarction, acute coronary syndromes, PCI or CABG (at average in 1.7 years of follow-up after index events). It is also true for other European countries, although certain differences exist between Russian and whole study population. In some respects, the results of secondary prevention in Russian patients were even more successful: e.g. effective blood pressure control was achieved in 73.4% of our patients taking antihypertensive drugs vs 53.5% in whole study population. In contrast, smoking was more prevalent among Russian patients (22.2% vs 15.0% in other countries). Obviously, it was related to lower frequency of smoking cessation support offered to our patients: only 1.1% were referred to a smoking cessation program, 3.2% were prescribed nicotine replacement therapy, none were prescribed varenicline (vs 18.6, 22.9, 6.2%, respectively, in whole study population). The Russian cohort had the highest rate of overweight and obesity compared to other European countries (93.1 vs 82.1% in whole study population). 74.9% our patients received lipid lowering drugs (vs 86.6% in Europe), although the LDL-C goal was achieved only in 15.9% of our patients taking lipid lowering drugs (vs 21.1% in whole study population).